You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-lymphocyte depletion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME) Trial in Norway (Rituximab, Placebo)

Completed
  • Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)
  • Bergen, Norway
  • +4 more
May 10, 2021

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Lymphocyte Depletion Trial in Charlottesville (SBRT with additional treatment planning dose optimization, SBRT with standard of

Recruiting
  • Lymphocyte Depletion
  • SBRT with additional treatment planning dose optimization
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Jul 16, 2021

Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)

Recruiting
  • Severe Combined Immunodeficiency
  • Anti-thymocyte globulin (rabbit)
  • +5 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 6, 2021

Nephrotic Syndrome Trial in Ranica (Blood sampling)

Recruiting
  • Nephrotic Syndrome
  • Blood sampling
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Jan 25, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

JAK-i on RA B-lymphocytes Tolerance and Disease Resolution

Recruiting
  • Rheumatoid Arthritis
  • B lymphocyte profiling
  • Rome, Italy
    Division of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023

Hematologic Malignancies Trial in Milwaukee (CliniMACs)

Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Apr 4, 2022

Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

Not yet recruiting
  • Non-hodgkin Lymphoma,B Cell
  • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
  • (no location specified)
Feb 14, 2023

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

Not yet recruiting
  • Digestive System Malignant Solid Tumors
  • ScTIL injection
  • ScTIL injection and B lymphocytes adjuvant
  • (no location specified)
Feb 7, 2023

Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

Not yet recruiting
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • +2 more
  • Biopsy
  • +9 more
  • (no location specified)
Jun 1, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

Withdrawn
  • Leukemia
  • Stem Cell Transplantation
  • Munich, Bavaria, Germany
    3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022

Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)

Recruiting
  • Sickle Cell Disease
  • Thalassemia Major
  • CliniMACS
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2021

Chronic Fatigue Syndrome Trial in Bergen (Rituximab, Saline (NaCl 0,9 %) ())

Completed
  • Chronic Fatigue Syndrome
  • Bergen, Norway
    Department of Oncology and Medical Physics, Haukeland University
May 10, 2021

Multiple Sclerosis Trial in Baltimore (Belimumab, Short-course Ocrelizumab, Continued Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Baltimore, Maryland
    Johns Hopkins University
Oct 7, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
Oct 21, 2021

Primary Membranous Nephropathy Trial in Beijing (B007)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Beijing, China
    Peking university first hospital
Dec 20, 2022

DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)

Recruiting
  • DLBCL
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Jul 1, 2022

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Non Hodgkin Lymphoma
  • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
  • Aurora, Colorado
    Children's Hospital Colorado
Nov 9, 2022